Cargando…
IL-1RA inhibits esophageal carcinogenesis and lymphangiogenesis via downregulating VEGF-C and MMP9
Interleukin-1 receptor antagonist (IL-1RA) has been shown to play an important role in cancer progression. However, its pathogenic effects and molecular mechanism in the malignant progression of esophageal squamous cell carcinoma (ESCC) remain largely unknown. This study was designed to explore the...
Autores principales: | Shen, Zhimin, Zhang, Peipei, Zhang, Weiguang, Luo, Fei, Xu, Hui, Chen, Shuchen, Kang, Mingqiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191916/ https://www.ncbi.nlm.nih.gov/pubmed/37198330 http://dx.doi.org/10.1007/s10142-023-01049-5 |
Ejemplares similares
-
TPM3 mediates epithelial-mesenchymal transition in esophageal cancer via MMP2/MMP9
por: Chen, Sui, et al.
Publicado: (2021) -
IL‐1RA suppresses esophageal cancer cell growth by blocking IL‐1α
por: Chen, Sui, et al.
Publicado: (2019) -
Development and validation of a prognostic model related to pyroptosis-related genes for esophageal squamous cell carcinoma using bioinformatics analysis
por: Zhang, Weiguang, et al.
Publicado: (2022) -
RASSF8 downregulation promotes lymphangiogenesis and metastasis in esophageal squamous cell carcinoma
por: Zhang, Lan, et al.
Publicado: (2015) -
Rapamycin suppresses angiogenesis and lymphangiogenesis in melanoma by downregulating VEGF-A/VEGFR-2 and VEGF-C/VEGFR-3 expression
por: Wang, Min, et al.
Publicado: (2019)